Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)

Market Cap	15.80B
Revenue	1.60B
Net Income	120.93M
Shares Out	581.97M
EPS	0.19
PE Ratio	129.76
Forward PE	44.84
Dividend	0.37 (1.36%)
Ex-Dividend Date	Jun 26, 2024

Volume	215,468
Open	27.31
Previous Close	27.25
Day's Range	n/a
52-Week Range	18.58 - 29.28
Beta	0.38
Analysts	n/a
Price Target	25.05 (-7.39%)
Earnings Date	May 28, 2024

About FPH

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1934
• Employees: 6,978
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: FPH

Financial Performance

In 2023, FPH's revenue was 1.76 billion, an increase of 18.24% compared to the previous year's 1.49 billion. Earnings were 132.60 million, a decrease of -47.02%.

Financial numbers in NZD